Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ii Robert C. Goeltz

CFO at Arcus Biosciences, Inc. (RCUS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $856K

Reported trades

Filed Stock Type Shares Price Value Since
May 12SEC RCUSArcus Biosciences, Inc. Sell Plan 7,76384,161 held (−8%) $25.63 $199K -4.8%
Jan 2SEC RCUSArcus Biosciences, Inc. Sell Plan 6,55267,924 held (−9%) $23.38 $153K +4.4%
Dec 18SEC RCUSArcus Biosciences, Inc. Sell Plan 6,70280,436 held (−8%) $21.88 $147K +11.6%
Dec 18SEC RCUSArcus Biosciences, Inc. Sell Plan 5,96074,476 held (−7%) $22.16 $132K +10.2%
Nov 26SEC RCUSArcus Biosciences, Inc. Sell Plan 5,00087,138 held (−5%) $25.00 $125K -2.4%
Oct 29SEC RCUSArcus Biosciences, Inc. Sell Plan 5,00092,138 held (−5%) $20.00 $100K +22.0%
  • Sell

    CFO Ii Robert C. Goeltz sold $199K of RCUS at $25.63 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ii Robert C. Goeltz sold $153K of RCUS at $23.38 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ii Robert C. Goeltz sold $147K of RCUS at $21.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ii Robert C. Goeltz sold $132K of RCUS at $22.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ii Robert C. Goeltz sold $125K of RCUS at $25.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ii Robert C. Goeltz sold $100K of RCUS at $20.00 — pre-scheduled 10b5-1 plan sale.